Market Overview:
The global insulin needle-free syringes market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in insulin needle-free syringes, and rising demand for minimally invasive procedures. Based on type, the global insulin needle-free syringes market is segmented into powder injections and liquid injections. The powder injection segment is expected to grow at a higher CAGR than the liquid injection segment during the forecast period from 2018 to 2030. This can be attributed to factors such as ease of use and accuracy offered by powder injectors over liquid injectors. Based on application, the global insulin needle-free syringes market is divided into hospital, clinic, and other applications segments. The hospital application segment dominates this market owing to high incidence of diabetes cases in hospitals across different regions worldwide. However, clinics are projected to witness highest growth rate during the forecast period from 2018to 2030 due growing preference for outpatient care settings among patients with diabetes mellitus (DM).
Product Definition:
Insulin needle-free syringes are devices that allow insulin to be injected without the use of a needle. They work by using compressed air or gas to push the insulin out of the syringe and into the skin. Insulin needle-free syringes are important because they can help reduce the risk of infection and other complications associated with traditional needles.
Powder Injections:
Insulin powder injections are a combination of fast acting insulin in the form of dry powder and premixed diluent. The product is designed to be used with needle-free injection technology, which involves the use of disposable pre-filled syringes.
Liquid Injections:
Insulin injections have been the conventional way of delivering insulin to diabetic patients. However, there are many disadvantages associated with it such as pain in abdomen, frequent injecting site visits and high risk of infection that has led to rapid shift towards alternative ways of insulin delivery like pen devices and pumps.
This shift in trend is mainly due to benefits offered by these alternative methods- Injections are time consuming.
Application Insights:
The hospital segment dominated the global insulin needle-free syringes market in 2017 and is expected to maintain its dominance over the forecast period. This can be attributed to a large number of hospitals across developing countries that still rely heavily on traditional methods of medication. Moreover, increasing investments by governments in building modern healthcare facilities are also likely to boost segment growth during the forecast period.
Clinic applications for insulin needle-free syringes are anticipated to witness significant growth over the next six years owing to an increase in demand for these injections at outpatient facilities and primary health centers. The growing prevalence of diabetes as well as rising awareness about this disease among individuals aged 40 years or more is also projected to drive demand from clinics during this study period.
Insulin injection errors may occur when patients inject themselves with extra insulin, which could lead to serious side effects such as hypoglycemia or hyperglycemia if proper care is not taken before.
Regional Analysis:
North America dominated the global insulin needle-free syringes market in 2017. This can be attributed to the presence of a large number of diabetes patients, increasing prevalence of chronic diseases such as diabetes and obesity, rising healthcare expenditure, and technological advancements in medical devices. Moreover, government initiatives for improving public health are also expected to boost product demand over the forecast period. For instance, according to CDC’s National Center for Health Statistics (NCHS), from 2015 to 2016 there were an estimated 9 million people with diagnosed diabetes in U.S.
Asia Pacific region is anticipated witness lucrative growth over the forecast period owing its large diabetic population base coupled with growing awareness about advanced treatment options especially Needle-free Syringes Injections (NFLI).
Growth Factors:
- Increasing prevalence of diabetes: The number of people with diabetes is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyle and dietary habits. According to the World Health Organization (WHO), the number of people with diabetes was estimated at 422 million in 2014 and is expected to reach 642 million by 2040. This will create a large pool of patients who will require insulin injections for treatment, thereby driving demand for insulin needle-free syringes.
- Technological advancements: The development of innovative technologies has led to the introduction of new products in the market, such as insulin needle-free syringes that are easier and more comfortable to use than traditional needles and syringes. These products are helping to increase patient compliance rates, which is driving growth in this market segment.
- Growing awareness about benefits offered by insulin needle-free syringes: There is growing awareness among patients about the benefits offered by these devices, such as ease of use, reduced pain levels, and fewer complications compared with traditional needles and syringes. This is helping to drive adoption rates for these devices worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Insulin Needle-free Syringes Market Research Report
By Type
Powder Injections, Liquid Injections
By Application
Hospital, Clinic, Other
By Companies
Zogenix, Inovio, Glide Pharma, Akra Dermojet, Crossject Medical Technology, Injex Pharma, Eternity Healthcare, Antares Pharma, Valeritas, Medical International Technologies, Penjet, PharmaJet, National Medical Products, Activa Brand Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Insulin Needle-free Syringes Market Report Segments:
The global Insulin Needle-free Syringes market is segmented on the basis of:
Types
Powder Injections, Liquid Injections
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zogenix
- Inovio
- Glide Pharma
- Akra Dermojet
- Crossject Medical Technology
- Injex Pharma
- Eternity Healthcare
- Antares Pharma
- Valeritas
- Medical International Technologies
- Penjet
- PharmaJet
- National Medical Products
- Activa Brand Products
Highlights of The Insulin Needle-free Syringes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder Injections
- Liquid Injections
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Insulin Needle-free Syringes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Insulin needle-free syringes are a type of insulin delivery device that uses a small, disposable needle to inject the insulin into the patient's body. This type of syringe is often preferred by patients who have difficulty using traditional insulin injection devices, such as those with arthritis or other physical limitations.
Some of the major companies in the insulin needle-free syringes market are Zogenix, Inovio, Glide Pharma, Akra Dermojet, Crossject Medical Technology, Injex Pharma, Eternity Healthcare, Antares Pharma, Valeritas, Medical International Technologies, Penjet, PharmaJet, National Medical Products, Activa Brand Products.
The insulin needle-free syringes market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Insulin Needle-free Syringes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Insulin Needle-free Syringes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Insulin Needle-free Syringes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Insulin Needle-free Syringes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Insulin Needle-free Syringes Market Size & Forecast, 2020-2028
4.5.1 Insulin Needle-free Syringes Market Size and Y-o-Y Growth
4.5.2 Insulin Needle-free Syringes Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Powder Injections
5.2.2 Liquid Injections
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Insulin Needle-free Syringes Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Insulin Needle-free Syringes Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Powder Injections
9.6.2 Liquid Injections
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Powder Injections
10.6.2 Liquid Injections
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Powder Injections
11.6.2 Liquid Injections
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Powder Injections
12.6.2 Liquid Injections
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Powder Injections
13.6.2 Liquid Injections
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Insulin Needle-free Syringes Market: Competitive Dashboard
14.2 Global Insulin Needle-free Syringes Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zogenix
14.3.2 Inovio
14.3.3 Glide Pharma
14.3.4 Akra Dermojet
14.3.5 Crossject Medical Technology
14.3.6 Injex Pharma
14.3.7 Eternity Healthcare
14.3.8 Antares Pharma
14.3.9 Valeritas
14.3.10 Medical International Technologies
14.3.11 Penjet
14.3.12 PharmaJet
14.3.13 National Medical Products
14.3.14 Activa Brand Products
